Zobrazeno 1 - 10
of 188
pro vyhledávání: '"Manash P. Baruah"'
Autor:
Manash P. Baruah, Pankaj Aneja, Shailesh Pitale, Abhijit Bhograj, Ritesh K. Agrawala, Ajay Aggarwal, Prasad G. Mahadev, Deepaklal C. Madhavdas, Sanjay Shah, Mathew John, Muzammil Khan. A. Pathan, Manjunatha Revanna, Manu Chandrappa, Kiran P. Singh
Publikováno v:
Journal of Family Medicine and Primary Care, Vol 13, Iss 9, Pp 3590-3597 (2024)
AIM: To investigate clinical outcomes in adults with type 2 diabetes (T2D) after insulin degludec/insulin aspart (IDegAsp) treatment in a real-world setting. Methods: The 26 weeks study involved 1102 adults with T2D who were either initiated with or
Externí odkaz:
https://doaj.org/article/87b874ff48994695a59411fb9f081792
Publikováno v:
Geology, Ecology, and Landscapes, Vol 0, Iss 0, Pp 1-14 (2020)
The geomorphic analysis of mountain fronts and related drainage networks can provide valuable insights about the recorded tectonic history of any given region especially when the area shows higher seismic activity in recent times. Therefore, such stu
Externí odkaz:
https://doaj.org/article/f760349b330e4080b7e0c74a0ffa255d
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 23, Iss 1, Pp 140-149 (2019)
Type 2 diabetes mellitus (T2DM) is a family of metabolic disorders characterized by hyperglycemia as a consequence of abnormalities in insulin secretion and insulin sensitivity. It affects hundreds of millions of people worldwide and leads to increas
Externí odkaz:
https://doaj.org/article/8f23196510994437943fb66d7025e500
Autor:
Sanjay Kalra, Sarita Bajaj, A G Unnikrishnan, Manash P Baruah, Rakesh Sahay, V Hardik, Amit Kumar
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 23, Iss 3, Pp 312-317 (2019)
Introduction: Dipeptidyl peptidase 4 (DPP4) inhibitors are widely used in type 2 diabetes mellitus (T2DM) patients but the data available in existing clinical trial programmes on DPP4 inhibitors include limited number of patients from India. Hence, t
Externí odkaz:
https://doaj.org/article/3b09c07d7aa64aa0821ff404733b7269
Autor:
Ashok Kumar Das, Viswanathan Mohan, Ambady Ramachandran, Sanjay Kalra, Ambrish Mithal, Rakesh Sahay, Mangesh Tiwaskar, Sambit Das, Manash P Baruah, Jubbin Jacob, Shehla Sheikh, Jothydev Kesavadav
Publikováno v:
Journal of the Association of Physicians of India. 70:69-78
The prevalence of prediabetes, a forerunner of diabetes is very high, and its conversion to diabetes is also more rapid among Asian Indians. Prediabetes also predisposes to the development of macrovascular and to a lesser extent of microvascular comp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d396a2dbe44bbe5353bdf8a38741a4d5
https://doi.org/10.5005/japi-11001-0162
https://doi.org/10.5005/japi-11001-0162
Publikováno v:
Endocrine and Metabolic Science, Vol 1, Iss 3, Pp 100057- (2020)
Introduction: Novel therapies, like the fixed dose coformulation of insulin degludec (100 U/ml) and liraglutide (3.6 mg/ml) (IDegLira), are key to achieving glycemic targets in some patients with difficult to control diabetes. Our objective was to ev
Externí odkaz:
https://doaj.org/article/846e78e6ce174fa1b401135121e3ab10
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 22, Iss 1, Pp 169-172 (2018)
Type 2 diabetes has emerged as a major threat to global public health. In spite of best efforts by health care professionals, persons with diabetes, and the community at large, remain unsatisfied with the approach to diabetes management .This brief c
Externí odkaz:
https://doaj.org/article/c53c70e6a9254e77842f746a91493adf
Autor:
Sanjay Kalra, Ambika G. Unnikrishnan, K. M. Prasanna Kumar, Rakesh Sahay, Hemraj B. Chandalia, Banshi Saboo, Sundaram Annamalai, Jothydev Kesavadev, Rishi Shukla, S. K. Wangnoo, Manash P. Baruah, Jubbin Jacob, Saurabh Arora, Rajiv Singla, Suresh K. Sharma, Suresh Damodaran, Ganapathi Bantwal
Publikováno v:
Diabetes Therapy. 14:29-45
With the emerging complexities in chronic diseases and people's lifestyles, healthcare professionals (HCPs) need to update their methods to manage and educate patients with chronic lifestyle disorders, particularly diabetes. The insulin injection tec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d859246377c2c3de63fa94e07ae2e112
https://doi.org/10.1007/s13300-022-01332-x
https://doi.org/10.1007/s13300-022-01332-x
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 21, Iss 3, Pp 443-452 (2017)
Introduction: Insulin remains the cornerstone of therapy in a substantial number of patients with type 2 diabetes mellitus (T2DM). Inadequate knowledge regarding insulin usage is likely to influence its acceptance and adherence, and outcome of therap
Externí odkaz:
https://doaj.org/article/c73c5afef9704e9982343e46aa3f0953
Autor:
Sanjay Kalra, Sujoy Ghosh, A H Aamir, Md. Tofail Ahmed, Mohammod Feroz Amin, Sarita Bajaj, Manash P Baruah, Uditha Bulugahapitiya, A K Das, Mimi Giri, Sonali Gunatilake, Saeed A Mahar, Md. Faruque Pathan, Nazmul Kabir Qureshi, S Abbas Raza, Rakesh Sahay, Santosh Shakya, Dina Shreshta, Noel Somasundaram, Manilka Sumanatilleke, A G Unnikrishnan, Achini Madushani Wijesinghe
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 21, Iss 1, Pp 210-230 (2017)
Diabetes prevalence shows a continuous increasing trend in South Asia. Although well-established treatment modalities exist for type 2 diabetes mellitus (T2DM) management, they are limited by their side effect profile. Sodium–glucose co-transporter
Externí odkaz:
https://doaj.org/article/db6ac62b57fb427e9d0d6d159e7bda54